Compare Jazz Pharmaceuticals (JAZZ) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Jazz Pharmaceuticals (JAZZ)

Price

$178.55

Change

-1.66%

Market Cap

$10.99B

Sector

Biotech

Biotech Sector Peers

All Biotech cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
INNPFInnocanPharma$5.070.00%$354.9M
CNVCFBioHarvest Sciences$5.71+1.33%$57.1M
ZYNEZynerba Pharmaceuticals$1.30+3.17%$33.8M
XXII22nd Century Group$3.88+1.97%$2.0M
OVATFOvation Science$0.020.00%$623.3K

Top Matchups by Market Cap

Companies closest to Jazz Pharmaceuticals in market capitalization — the most meaningful head-to-head comparisons.

SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Biotech sector. Compare across different business models and market segments.

SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare

Comparing JAZZ in the Cannabis Market

Jazz Pharmaceuticals (JAZZ) is a Biotech-sector cannabis company trading at $178.55 per share with a market capitalization of $10.99B. Among its Biotech peers, JAZZ ranks first by market cap, with trailing twelve-month revenue of $4.16B and a gross margin of 0.0%. The stock has moved -1.66% in the current session, trading on the NASDAQ exchange.

When comparing JAZZ against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (2.6x), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $5.36B). The comparison tables above allow you to evaluate Jazz Pharmaceuticals relative to 5 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does JAZZ compare to other Biotech stocks?+
Jazz Pharmaceuticals has a market cap of $10.99B, placing it among 6 companies in the Biotech sector. Its price-to-sales ratio is 2.6x and its gross margin is 0.0%. Use the table above to compare these metrics against every Biotech peer.
What is JAZZ's biggest competitor?+
By market capitalization, the closest comparable company is Scotts Miracle-Gro (SMG) with a market cap of $3.54B. Click the compare link to view a full head-to-head analysis.
Is JAZZ overvalued compared to its peers?+
Jazz Pharmaceuticals trades at a P/S ratio of 2.6x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than JAZZ?+
Jazz Pharmaceuticals has a gross margin of 0.0%. Among its Biotech peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare JAZZ to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Biotech. You can click any company to see a full side-by-side comparison with JAZZ covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.